Skip to main content

Digital Diabetes Management Industry is Growing at a CAGR of 23.8%


The rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly flexible solutions in the market. These are the major factors driving the growth of the global digital diabetes management market. The increasing adoption of cloud-based enterprise solutions and the growing use of connected devices and apps are some of the other major factors supporting market growth.

Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes.



The digital diabetes management market
is projected to reach USD 19.98 billion by 2024, from an estimated USD 6.87 billion in 2019, at a CAGR of 23.8%.

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, competitive leadership mapping, key market dynamics, and key player strategies.

Key Questions Addressed in The Report:

1. Who are the top 10 players operating in the global Digital Diabetes Management market?
2. What are the drivers, restraints, opportunities, and challenges in the Digital Diabetes Management Industry?
3. What are the
opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of Digital Diabetes Management in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144725893

Diabetes Management Devices Segment:

The large share of this segment can be attributed to the growing demand for wireless and wearable devices for diabetes management, increasing acceptance of smart insulin pumps and pens for insulin delivery, and the increasing awareness about continuous glucose monitoring in patients.

Wearable Devices Segment:

The increasing awareness about glucose monitoring; growth in the number of regulatory approvals for CGM systems; development of advanced wearable products such as closed-loop pump systems and smart insulin patches (and pipeline devices such as contact lenses and smartwatches synced with glucometers); and the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery are the major factors driving the growth of the wearable devices market.

Regional Growth and Demand Analysis:

North America to dominate the market. This can primarily be attributed to the high adoption of connected diabetes management devices and apps, growing demand for closed-loop systems, high adoption of remote online coaching services for diabetes management, favorable reimbursement policies, and government initiatives to promote digital health in the region.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=144725893

Key Players:

Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel) are key players in Digital Diabetes Management Market.

Comments

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...